Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 15/20 | 0.50 |
| ▸ | CTSB | P07858 | 3/20 | 0.50 |
| ▸ | CAPN9 | O14815 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.50 |
| ▸ | CTSH | P09668 | 1/20 | 0.50 |
| ▸ | CTSS | P25774 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230639 | 0.85 | CAPN1 (0.52) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL9089222 | 0.84 | CAPN1 (0.51) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL11067480 | 0.78 | CAPN1 (0.74) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| Agmatine SCHEMBL18784085 | 0.77 | CAPN1 (0.59) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL11184932 | 0.77 | CAPN1 (0.72) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL11188762 | 0.77 | CAPN1 (0.72) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL15281236 | 0.75 | CAPN1 (0.64) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL6069773 | 0.75 | CAPN1 (0.64) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL6069840 | 0.75 | CAPN1 (0.64) | CAPN1CTSBCAPN9CTSKMAPK1 | |
| SCHEMBL212151 | 0.74 | CAPN1 (0.60) | CAPN1CTSBCAPN9CTSKMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6518062-B1 | Enhanced toxicity of nucleoside analogues; enzymatic phosphorylation; kinases; vector enabled intracelluar expression and transfer; use anti-cancer gene therapy | AVENTIS PHARMA S.A. (FR) | 2003-02-11 | — | — | US | disclosed |